Re: Slight Change of topic
|
8
|
Resverlogix Corp.
|
May 24, 2017 10:09PM
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
5
|
Resverlogix Corp.
|
May 26, 2017 10:21AM
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
5
|
Resverlogix Corp.
|
May 26, 2017 02:27PM
|
Re: An upcoming ATB blog post....soliciting constructive criticism:
|
|
Resverlogix Corp.
|
May 28, 2017 06:29PM
|
Re: Don't see us on the list at Bio-International either....
|
3
|
Resverlogix Corp.
|
May 30, 2017 06:35AM
|
Re: madrid
|
2
|
Resverlogix Corp.
|
May 30, 2017 06:42AM
|
Re: We're not on the list of exhibitors for San Diego....
|
2
|
Resverlogix Corp.
|
May 30, 2017 06:48AM
|
Re: We're not on the list of exhibitors for San Diego....
|
|
Resverlogix Corp.
|
May 30, 2017 08:01AM
|
Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone
|
2
|
Resverlogix Corp.
|
May 30, 2017 12:31PM
|
Likelihood of BETonMACE getting FDA/US involvement
|
1
|
Resverlogix Corp.
|
May 30, 2017 01:16PM
|
Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone
|
6
|
Resverlogix Corp.
|
May 30, 2017 02:52PM
|
Re: NR on Madrid conferece
|
1
|
Resverlogix Corp.
|
May 31, 2017 09:44AM
|
Re: Resverlogix To Host Epigenetics Focused Symposium At The ERA-EDTA Congress in Madrid, Spain
|
1
|
Resverlogix Corp.
|
May 31, 2017 09:52AM
|
Re: Reading The Tea Leaves
|
2
|
Resverlogix Corp.
|
May 31, 2017 12:29PM
|
New RVX-208 paper on downregulation of the complement cascade
|
4
|
Resverlogix Corp.
|
Jun 01, 2017 01:49PM
|
Quiet Before the Bang
|
|
BIOASIS TECHNOLOGIES INC
|
Jun 01, 2017 02:06PM
|
Questioning Expectations vs. Results
|
|
BIOASIS TECHNOLOGIES INC
|
Jun 01, 2017 02:15PM
|
Re: New compound - ApaBearDownAzone
|
5
|
Resverlogix Corp.
|
Jun 01, 2017 03:23PM
|
Endocrine News
|
8
|
Resverlogix Corp.
|
Jun 01, 2017 10:40PM
|
Re: Endocrine News
|
6
|
Resverlogix Corp.
|
Jun 02, 2017 06:46AM
|